Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Amortizatization of Intangibles (2022 - 2025)

Atara Biotherapeutics (ATRA) has disclosed Amortizatization of Intangibles for 3 consecutive years, with $891000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Amortizatization of Intangibles fell 18.03% year-over-year to $891000.0, compared with a TTM value of $3.6 million through Sep 2025, down 14.47%, and an annual FY2024 reading of $4.1 million, down 14.25% over the prior year.
  • Amortizatization of Intangibles was $891000.0 for Q3 2025 at Atara Biotherapeutics, down from $957000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $2.1 million in Q2 2023 and bottomed at $351000.0 in Q1 2023.
  • Average Amortizatization of Intangibles over 3 years is $1.1 million, with a median of $1.0 million recorded in 2024.
  • Peak annual rise in Amortizatization of Intangibles hit 198.01% in 2024, while the deepest fall reached 50.26% in 2024.
  • Year by year, Amortizatization of Intangibles stood at $1.1 million in 2023, then fell by 12.61% to $929000.0 in 2024, then fell by 4.09% to $891000.0 in 2025.
  • Business Quant data shows Amortizatization of Intangibles for ATRA at $891000.0 in Q3 2025, $957000.0 in Q2 2025, and $852000.0 in Q1 2025.